MC-1101

· MacuCLEAR, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MC-1101, covering 2009-11-13 to 2014-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration [Phase 2, Phase 3]

See pricing